India is the King of the World Hydroxy Chloroquine Drug Procurement, which is considered to be effective against Covid 19. India is one of the safest places in the collection of medicines. The top three companies in India make up 70% of the world market. India also has the potential to produce 40 tonnes of the drug (20 million tablets of 200 mg) in 30 days.
Kerala is safe
Kerala is also safe in terms of drug stock. With a total of 11.5 lakh tablets sanctioned by the Center, there is a total collection of 14 lakh tablets in the state. It can be used for one lakh patients. In addition, the government has also considered licensing Kerala State Drugs and Pharmaceuticals for manufacturing drugs. Due to the suggestion that unnecessary stock of raw materials is wasted due to the lack of sufficient stock, it was rejected.
Collection of ∙ 1.42 crores
A Covid patient may need to take 14 tablets of 200 mg per course. That means India’s monthly output of 1.42 crore patients can be cured. Hydroxychloroquine is mainly produced by Ipka Laboratories (Mumbai), Cides Cadilla (Ahmedabad) and Wallace Pharmaceuticals (Goa).
Control over sales
The drug, which is seldom used, became increasingly popular with the outbreak of Covid-19. With the addition of WhatsApp messages from some doctors in North India, the wealthy began to buy drugs. The drug, as it had been for three months, had reached a cost of one day. With this, the hydroxychloroquine schedule was added to the H-1 category at the end of March. It was not possible to sell the medicine without a prescription.